Top Markets
#1 Black Phoenix Black Phoenix +356.40%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +59.85%
#4 Gold Park Gold Park +56.34%
#5 Acurast Acurast +37.87%
#6 BasedHype BasedHype +26.41%
#7 OpenEden OpenEden +24.88%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.34%
#9 Cryptopia Cryptopia +21.54%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +15.54%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Rangering i aksjer #40886
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Aksjekurs
$0.0127
Sist synkronisert: 2026-08-12
Markedsverdi
$66.48K
Endring (1 dag)
-2.31%
Endring (1 år)
-67.44%
Land
US
Handel Vincerx Pharma, Inc. (VINC)

Kategori

Healthcare
EPS for Vincerx Pharma, Inc. (VINC)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Vincerx Pharma, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Vincerx Pharma, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE